Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma. (Q40563034)
Jump to navigation
Jump to search
scientific article published on 17 April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma. |
scientific article published on 17 April 2004 |
Statements
Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma (English)
Rieko Katayama
Michael K Huelsmeyer
Amanda K Marr
Ilene D Kurzman
1 reference